-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Jazz Pharmaceuticals plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- Jazz Pharmaceuticals plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 63.2M shares, a 11.4% decline year-over-year.
- Jazz Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 72.1M shares, a 15.2% increase from 2022.
- Jazz Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 62.5M shares, a 4.77% increase from 2021.
- Jazz Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 59.7M shares, a 5.62% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)